Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Dynamics of Vaginal and Rectal Microbiota Over Several Menstrual Cycles in Female Cynomolgus Macaques.

Nugeyre MT, Tchitchek N, Adapen C, Cannou C, Contreras V, Benjelloun F, Ravel J, Le Grand R, Marlin R, Menu E.

Front Cell Infect Microbiol. 2019 Jun 12;9:188. doi: 10.3389/fcimb.2019.00188. eCollection 2019.

2.

Seminal Plasma Exposures Strengthen Vaccine Responses in the Female Reproductive Tract Mucosae.

Marlin R, Nugeyre MT, Tchitchek N, Parenti M, Lefebvre C, Hocini H, Benjelloun F, Cannou C, Nozza S, Dereuddre-Bosquet N, Levy Y, Barré-Sinoussi F, Scarlatti G, Le Grand R, Menu E.

Front Immunol. 2019 Mar 12;10:430. doi: 10.3389/fimmu.2019.00430. eCollection 2019.

3.

Modified Vaccinia Virus Ankara Vector Induces Specific Cellular and Humoral Responses in the Female Reproductive Tract, the Main HIV Portal of Entry.

Marlin R, Nugeyre MT, Tchitchek N, Parenti M, Hocini H, Benjelloun F, Cannou C, Dereuddre-Bosquet N, Levy Y, Barré-Sinoussi F, Scarlatti G, Le Grand R, Menu E.

J Immunol. 2017 Sep 1;199(5):1923-1932. doi: 10.4049/jimmunol.1700320. Epub 2017 Jul 31.

4.

NK cells control HIV-1 infection of macrophages through soluble factors and cellular contacts in the human decidua.

Quillay H, El Costa H, Duriez M, Marlin R, Cannou C, Madec Y, de Truchis C, Rahmati M, Barré-Sinoussi F, Nugeyre MT, Menu E.

Retrovirology. 2016 Jun 6;13(1):39. doi: 10.1186/s12977-016-0271-z.

5.

The local environment orchestrates mucosal decidual macrophage differentiation and substantially inhibits HIV-1 replication.

El Costa H, Quillay H, Marlin R, Cannou C, Duriez M, Benjelloun F, de Truchis C, Rahmati M, Ighil J, Barré-Sinoussi F, Nugeyre MT, Menu E.

Mucosal Immunol. 2016 May;9(3):634-46. doi: 10.1038/mi.2015.87. Epub 2015 Sep 9.

6.

Distinct characteristics of endometrial and decidual macrophages and regulation of their permissivity to HIV-1 infection by SAMHD1.

Quillay H, El Costa H, Marlin R, Duriez M, Cannou C, Chrétien F, Fernandez H, Lebreton A, Ighil J, Schwartz O, Barré-Sinoussi F, Nugeyre MT, Menu E.

J Virol. 2015 Jan 15;89(2):1329-39. doi: 10.1128/JVI.01730-14. Epub 2014 Nov 12.

7.

Human decidual macrophages and NK cells differentially express Toll-like receptors and display distinct cytokine profiles upon TLR stimulation.

Duriez M, Quillay H, Madec Y, El Costa H, Cannou C, Marlin R, de Truchis C, Rahmati M, Barré-Sinoussi F, Nugeyre MT, Menu E.

Front Microbiol. 2014 Jul 1;5:316. doi: 10.3389/fmicb.2014.00316. eCollection 2014.

8.

Dynamic shift from CD85j/ILT-2 to NKG2D NK receptor expression pattern on human decidual NK during the first trimester of pregnancy.

Marlin R, Duriez M, Berkane N, de Truchis C, Madec Y, Rey-Cuille MA, Cummings JS, Cannou C, Quillay H, Barré-Sinoussi F, Nugeyre MT, Menu E.

PLoS One. 2012;7(1):e30017. doi: 10.1371/journal.pone.0030017. Epub 2012 Jan 5.

9.

Decidual soluble factors participate in the control of HIV-1 infection at the maternofetal interface.

Marlin R, Nugeyre MT, Duriez M, Cannou C, Le Breton A, Berkane N, Barré-Sinoussi F, Menu E.

Retrovirology. 2011 Jul 18;8:58. doi: 10.1186/1742-4690-8-58.

10.

Antigen-presenting cells represent targets for R5 HIV-1 infection in the first trimester pregnancy uterine mucosa.

Marlin R, Nugeyre MT, de Truchis C, Berkane N, Gervaise A, Barré-Sinoussi F, Menu E.

PLoS One. 2009 Jun 22;4(6):e5971. doi: 10.1371/journal.pone.0005971.

11.

Gag p27-specific B- and T-cell responses in Simian immunodeficiency virus SIVagm-infected African green monkeys.

Lozano Reina JM, Favre D, Kasakow Z, Mayau V, Nugeyre MT, Ka T, Faye A, Miller CJ, Scott-Algara D, McCune JM, Barré-Sinoussi F, Diop OM, Müller-Trutwin MC.

J Virol. 2009 Mar;83(6):2770-7. doi: 10.1128/JVI.01841-08. Epub 2008 Dec 24.

12.
13.

Ex vivo characterization of human thymic dendritic cell subsets.

Schmitt N, Cumont MC, Nugeyre MT, Hurtrel B, Barré-Sinoussi F, Scott-Algara D, Israël N.

Immunobiology. 2007;212(3):167-77. Epub 2007 Mar 13.

PMID:
17412284
14.

Population-based sequencing of the V3 region of env for predicting the coreceptor usage of human immunodeficiency virus type 1 quasispecies.

Delobel P, Nugeyre MT, Cazabat M, Pasquier C, Marchou B, Massip P, Barre-Sinoussi F, Israël N, Izopet J.

J Clin Microbiol. 2007 May;45(5):1572-80. Epub 2007 Feb 28.

15.

Naive T-cell depletion related to infection by X4 human immunodeficiency virus type 1 in poor immunological responders to highly active antiretroviral therapy.

Delobel P, Nugeyre MT, Cazabat M, Sandres-Sauné K, Pasquier C, Cuzin L, Marchou B, Massip P, Cheynier R, Barré-Sinoussi F, Izopet J, Israël N.

J Virol. 2006 Oct;80(20):10229-36.

16.

Differential susceptibility of human thymic dendritic cell subsets to X4 and R5 HIV-1 infection.

Schmitt N, Nugeyre MT, Scott-Algara D, Cumont MC, Barré-Sinoussi F, Pancino G, Israël N.

AIDS. 2006 Feb 28;20(4):533-42.

PMID:
16470117
17.

IL-7 induces immunological improvement in SIV-infected rhesus macaques under antiviral therapy.

Beq S, Nugeyre MT, Ho Tsong Fang R, Gautier D, Legrand R, Schmitt N, Estaquier J, Barré-Sinoussi F, Hurtrel B, Cheynier R, Israël N.

J Immunol. 2006 Jan 15;176(2):914-22.

18.

Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). 1983.

Barré-Sinoussi F, Chermann JC, Rey F, Nugeyre MT, Chamaret S, Gruest J, Dauguet C, Axler-Blin C, Vézinet-Brun F, Rouzioux C, Rozenbaum W, Montagnier L.

Rev Invest Clin. 2004 Mar-Apr;56(2):126-9. No abstract available.

PMID:
15378805
19.

IL-7 stimulates T cell renewal without increasing viral replication in simian immunodeficiency virus-infected macaques.

Nugeyre MT, Monceaux V, Beq S, Cumont MC, Ho Tsong Fang R, Chêne L, Morre M, Barré-Sinoussi F, Hurtrel B, Israël N.

J Immunol. 2003 Oct 15;171(8):4447-53.

20.

Positive regulation of CXCR4 expression and signaling by interleukin-7 in CD4+ mature thymocytes correlates with their capacity to favor human immunodeficiency X4 virus replication.

Schmitt N, Chêne L, Boutolleau D, Nugeyre MT, Guillemard E, Versmisse P, Jacquemot C, Barré-Sinoussi F, Israël N.

J Virol. 2003 May;77(10):5784-93.

21.

Interleukin-7 and infection itself by human immunodeficiency virus 1 favor virus persistence in mature CD4(+)CD8(-)CD3(+) thymocytes through sustained induction of Bcl-2.

Guillemard E, Nugeyre MT, Chêne L, Schmitt N, Jacquemot C, Barré-Sinoussi F, Israël N.

Blood. 2001 Oct 1;98(7):2166-74.

PMID:
11568004
23.
24.

Human immunodeficiency virus induces a dual regulation of Bcl-2, resulting in persistent infection of CD4(+) T- or monocytic cell lines.

Aillet F, Masutani H, Elbim C, Raoul H, Chêne L, Nugeyre MT, Paya C, Barré-Sinoussi F, Gougerot-Pocidalo MA, Israël N.

J Virol. 1998 Dec;72(12):9698-705.

25.

Contact with thymic epithelial cells as a prerequisite for cytokine-enhanced human immunodeficiency virus type 1 replication in thymocytes.

Rothe M, Chêne L, Nugeyre MT, Braun J, Barré-Sinoussi F, Israël N.

J Virol. 1998 Jul;72(7):5852-61.

26.

Productive and persistent infection of human thymic epithelial cells in vitro with HIV-1.

Braun J, Valentin H, Nugeyre MT, Ohayon H, Gounon P, Barré-Sinoussi F.

Virology. 1996 Nov 15;225(2):413-8.

27.

Flow cytometric analysis of protein-tyrosine phosphorylation in peripheral T cell subsets. Application to healthy and HIV-seropositive subjects.

Vuillier F, Scott-Algara D, Cayota A, Siciliano J, Nugeyre MT, Dighiero G.

J Immunol Methods. 1995 Sep 11;185(1):43-56.

PMID:
7545200
28.

Two subpopulations of human triple-negative thymic cells are susceptible to infection by human immunodeficiency virus type 1 in vitro.

Valentin H, Nugeyre MT, Vuillier F, Boumsell L, Schmid M, Barré-Sinoussi F, Pereira RA.

J Virol. 1994 May;68(5):3041-50.

29.

LAV revisited: origins of the early HIV-1 isolates from Institut Pasteur.

Wain-Hobson S, Vartanian JP, Henry M, Chenciner N, Cheynier R, Delassus S, Martins LP, Sala M, Nugeyre MT, Guétard D, et al.

Science. 1991 May 17;252(5008):961-5.

PMID:
2035026
30.

Cis elements and trans-acting factors involved in the RNA dimerization of the human immunodeficiency virus HIV-1.

Darlix JL, Gabus C, Nugeyre MT, Clavel F, Barré-Sinoussi F.

J Mol Biol. 1990 Dec 5;216(3):689-99.

PMID:
2124274
31.

HIV-1 reverse transcriptase specifically interacts with the anticodon domain of its cognate primer tRNA.

Barat C, Lullien V, Schatz O, Keith G, Nugeyre MT, Grüninger-Leitch F, Barré-Sinoussi F, LeGrice SF, Darlix JL.

EMBO J. 1989 Nov;8(11):3279-85.

32.

Replication of the human immunodeficiency virus 1 and impaired differentiation of T cells after in vitro infection of bone marrow immature T cells.

Lunardi-Iskandar Y, Nugeyre MT, Georgoulias V, Barré-Sinoussi F, Jasmin C, Chermann JC.

J Clin Invest. 1989 Feb;83(2):610-5.

33.

Peripheral blood adherent cells from AIDS patients inhibit normal T-colony growth through decreased expression of interleukin 2-receptors and production of interleukin 2.

Lunardi-Iskandar Y, Georgoulias V, Vittecoq D, Nugeyre MT, Ammar A, Clemenceau C, Barre-Sinoussi F, Chermann JC, Schwartzenberg L, Jasmin C.

Leuk Res. 1987;11(8):753-60.

PMID:
3114567
34.

[Infection of insect cell lines by the HIV virus, an agent of AIDS, and a demonstration of insects of African origin infected by this virus].

Becker JL, Hazan U, Nugeyre MT, Rey F, Spire B, Barré-Sinoussi F, Georges A, Teulières L, Chermann JC.

C R Acad Sci III. 1986;303(8):303-6. French.

PMID:
3094848
35.

Resistance of AIDS virus at room temperature.

Barre-Sinoussi F, Nugeyre MT, Chermann JC.

Lancet. 1985 Sep 28;2(8457):721-2. No abstract available.

PMID:
2863698
36.

Laboratory and serological studies argue against possible transmission of AIDS by hepatitis B vaccine.

Barré-Sinoussi F, Nugeyre MT, Girard M, Tron F, Chermann JC.

Lancet. 1985 Aug 3;2(8449):274. No abstract available.

PMID:
2410750
37.

Adaptation of lymphadenopathy associated virus (LAV) to replication in EBV-transformed B lymphoblastoid cell lines.

Montagnier L, Gruest J, Chamaret S, Dauguet C, Axler C, Guétard D, Nugeyre MT, Barré-Sinoussi F, Chermann JC, Brunet JB, et al.

Science. 1984 Jul 6;225(4657):63-6.

PMID:
6328661
38.

Selective tropism of lymphadenopathy associated virus (LAV) for helper-inducer T lymphocytes.

Klatzmann D, Barré-Sinoussi F, Nugeyre MT, Danquet C, Vilmer E, Griscelli C, Brun-Veziret F, Rouzioux C, Gluckman JC, Chermann JC, et al.

Science. 1984 Jul 6;225(4657):59-63.

PMID:
6328660
39.

Isolation of human T-lymphotropic retrovirus (LAV) from Zairian married couple, one with AIDS, one with prodromes.

Ellrodt A, Barre-Sinoussi F, Le Bras P, Nugeyre MT, Palazzo L, Rey F, Brun-Vezinet F, Rouzioux C, Segond P, Caquet R, et al.

Lancet. 1984 Jun 23;1(8391):1383-5.

PMID:
6145837
40.

Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS).

Barré-Sinoussi F, Chermann JC, Rey F, Nugeyre MT, Chamaret S, Gruest J, Dauguet C, Axler-Blin C, Vézinet-Brun F, Rouzioux C, Rozenbaum W, Montagnier L.

Science. 1983 May 20;220(4599):868-71.

PMID:
6189183
41.

[On the mechanism of icterus due to biliary obstruction, after the 4th day].

Mallet-Guy P, Michoulier J, Kesner LF, Nugeyre M.

Lyon Chir. 1967 Jan;63(1):17-20. French. No abstract available.

PMID:
6043277
42.

[Lymphatic circulation of the liver in experimental toxic hepatitis].

Mallet-Guy P, Michoulier J, Feroldi J, Nugeyre M, Castelfranchi PL.

Bull Soc Int Chir. 1966 Jan-Feb;25(1):76-82. French. No abstract available.

PMID:
5932557
43.

[EXPERIMENTAL RESEARCH ON LYMPHATIC CIRCULATION OF THE LIVER. IV. BILIO-LYMPHATIC PERMEATION IN TOXIC HEPATITIS].

MALLET GUY P, MICHOULIER J, FEROLDI J, CASTELFRANCHI PL, NUGEYRE M.

Lyon Chir. 1964 Jul;60:525-30. French. No abstract available.

PMID:
14208265

Supplemental Content

Loading ...
Support Center